Florian Schønharting
Florian Schønharting er aktiv i 16 virksomheder
I virksomheden TECH GROWTH INVEST ApS er Florian Schønharting reelle ejere, direktion og bestyrelse.
Florian Schønharting er aktiv I mange forskellige virksomheder.
Han er direktør i 9 virksomheder.
Florian Schønharting er desuden medlem af bestyrelsen i 6 virksomheder.
Se alle Florian Schønhartings roller her
Florian Schønharting startede sin erhvervskarriere i Danmark i 1999, i virksomheden AKTIESELSKABET BI BIOMEDICINSK VENTURE II. Her startede Florian Schønharting som og direktion. Virksomheden er dog ikke aktiv længere. Florian Schønharting havde en rolle i virksomheden i 1 år.
Selskaber
16
Direktørposter
9
Bestyrelsesposter
6
Forbindelser
-
Aktuelle roller
| Aktuelle roller | Bruttofortjeneste | Årets resultat | Balance |
|---|---|---|---|
TECH GROWTH INVEST ApSBestyrelse, Direktion, Reelle ejere |
-84 DKK | -4.993 DKK | 16.869 DKK |
NORDIC BIOTECH ADVISORS ApSDirektion, Bestyrelse, Reelle ejere |
3.812 DKK | 943 DKK | 4.261 DKK |
NORDIC BIOTECH GENERAL PARTNER ApSDirektion, Reelle ejere |
12 DKK | 4 DKK | 955 DKK |
NORDIC BIOTECH PRIVATE INVESTORS ApSDirektion |
-20 DKK | -1.037 DKK | 1.490 DKK |
NORDIC BIOTECH INCENTIVE ApSDirektion |
-18 DKK | -2.262 DKK | 1.734 DKK |
NB PUBLIC EQUITY INVEST ApSReelle ejere |
-47 DKK | -649 DKK | 5.557 DKK |
NB PUBLIC EQUITY KOMPLEMENTAR ApSReelle ejere |
267 DKK | -1 DKK | 1.876 DKK |
NB PUBLIC EQUITY K/SReelle ejere |
- DKK | - DKK | - DKK |
FORWARD PHARMA A/SBestyrelse |
-11.632 DKK | -31.483 DKK | 529.878 DKK |
NB FP INVESTMENT SLP ApSDirektion, Reelle ejere |
-26 DKK | -1.259 DKK | 2.171 DKK |
NB FP INVESTMENT GENERAL PARTNER ApSEJERREGISTER, Direktion, Reelle ejere |
58 DKK | -7 DKK | 447 DKK |
Holdingselskabet af 1 januar 2016 ApSEJERREGISTER, Reelle ejere, Direktion |
-85 DKK | -4.628 DKK | 33.146 DKK |
NB FP INVESTMENT K/SReelle ejere |
- DKK | - DKK | - DKK |
NORDIC BIOTECH K/SReelle ejere |
- DKK | - DKK | - DKK |
NORDIC BIOTECH OPPORTUNITY FUND K/SReelle ejere |
- DKK | - DKK | - DKK |
NB FP INVESTMENT II K/SReelle ejere |
- DKK | - DKK | - DKK |
Direktørposter
-
2017 – nu
Direktion
Holdingselskabet af 1 januar 2016 ApS -
2013 – nu
Direktion
NB FP INVESTMENT SLP ApS -
2013 – nu
Direktion
NB FP INVESTMENT GENERAL PARTNER ApS -
2012 – nu
Direktion
NORDIC BIOTECH INCENTIVE ApS -
2012 – nu
Direktion
NORDIC BIOTECH PRIVATE INVESTORS ApS -
2010 – nu
Direktion
NORDIC BIOTECH ADVISORS ApS -
2010 – nu
Direktion
NORDIC BIOTECH GENERAL PARTNER ApS -
2001 – nu
Direktion
TECH GROWTH INVEST ApS -
2007 – 2008
Direktion
NB PUBLIC EQUITY INVEST ApS
Bestyrelsesposter
-
2012 – nu
Bestyrelse
FORWARD PHARMA A/S -
2002 – nu
Bestyrelse
TECH GROWTH INVEST ApS -
2001 – nu
Bestyrelse
NORDIC BIOTECH ADVISORS ApS -
2003 – 2012
Bestyrelse
NORDIC BIOTECH INCENTIVE ApS -
2001 – 2012
Bestyrelse
NORDIC BIOTECH PRIVATE INVESTORS ApS -
2003 – 2010
Bestyrelse
NORDIC BIOTECH GENERAL PARTNER ApS
Relationer
Florian Schønharting
| Christian Karsten Hansen | (5 relationer) |
| Jakob Mosegaard Larsen | (5 relationer) |
| Claus Bo Søndergaard Svendsen | (4 relationer) |
Ejerforhold
| Virksomhed | Ejerandel | Bruttofortjeneste | Årets resultat | Balance |
|---|---|---|---|---|
TECH GROWTH INVEST ApS |
100 %
|
-84 DKK | -4.993 DKK | 16.869 DKK |
NORDIC BIOTECH ADVISORS ApS |
45 %
|
3.812 DKK | 943 DKK | 4.261 DKK |
NORDIC BIOTECH GENERAL PARTNER ApS |
45 %
|
12 DKK | 4 DKK | 955 DKK |
NB PUBLIC EQUITY INVEST ApS |
50 %
|
-47 DKK | -649 DKK | 5.557 DKK |
NB PUBLIC EQUITY KOMPLEMENTAR ApS |
45 %
|
267 DKK | -1 DKK | 1.876 DKK |
NB PUBLIC EQUITY K/S |
0,26 %
|
- DKK | - DKK | - DKK |
NB FP INVESTMENT SLP ApS |
75 %
|
-26 DKK | -1.259 DKK | 2.171 DKK |
NB FP INVESTMENT GENERAL PARTNER ApS |
66,67 %
|
58 DKK | -7 DKK | 447 DKK |
Holdingselskabet af 1 januar 2016 ApS |
100 %
|
-85 DKK | -4.628 DKK | 33.146 DKK |
NB FP INVESTMENT K/S |
0 %
|
- DKK | - DKK | - DKK |
NORDIC BIOTECH K/S |
0 %
|
- DKK | - DKK | - DKK |
NORDIC BIOTECH OPPORTUNITY FUND K/S |
0 %
|
- DKK | - DKK | - DKK |
NB FP INVESTMENT II K/S |
0 %
|
- DKK | - DKK | - DKK |
Alle Florian Schønharting relationer
| Relation | Virksomhed | Rolle |
|---|---|---|
Jakob Mosegaard Larsen |
FORWARD PHARMA A/S |
Bestyrelse
20-07-2015 -
|
Jakob Mosegaard Larsen |
Forward Pharma FA ApS |
Bestyrelse
03-12-2015 -
|
Jakob Mosegaard Larsen |
FWP IP ApS |
Reelle ejere
22-11-2017 -
Bestyrelse 22-11-2017 - |
Jakob Mosegaard Larsen |
NORDIC BIOTECH ADVISORS ApS |
Bestyrelse
05-12-2011 -
|
Jakob Mosegaard Larsen |
NB PUBLIC EQUITY KOMPLEMENTAR ApS |
Stiftere
03-09-2008 -
|
Christian Karsten Hansen |
NORDIC BIOTECH GENERAL PARTNER ApS |
Reelle ejere
28-09-2001 -
|
Christian Karsten Hansen |
NB PUBLIC EQUITY INVEST ApS |
Reelle ejere
02-09-2008 -
|
Christian Karsten Hansen |
NORDIC BIOTECH ADVISORS ApS |
Reelle ejere
29-06-2001 -
|
Christian Karsten Hansen |
NB PUBLIC EQUITY K/S |
Reelle ejere
04-09-2008 -
|
Christian Karsten Hansen |
NB PUBLIC EQUITY KOMPLEMENTAR ApS |
Reelle ejere
03-09-2008 -
|
Claus Bo Søndergaard Svendsen |
FORWARD PHARMA A/S |
Direktion
01-03-2017 -
|
Claus Bo Søndergaard Svendsen |
Forward Pharma Operations ApS |
Direktion
30-06-2017 -
|
Claus Bo Søndergaard Svendsen |
Forward Pharma FA ApS |
Direktion
31-05-2017 -
Bestyrelse 31-05-2017 - |
Claus Bo Søndergaard Svendsen |
FWP IP ApS |
Direktion
30-06-2017 -
|
Duncan Charles Mcnaught Moore |
NORDIC BIOTECH PRIVATE INVESTORS ApS |
EJERREGISTER
13-06-2006 -
Reelle ejere 28-09-2001 - |
Biotechnology Value Fund II, L.P. |
NB FP INVESTMENT K/S |
EJERREGISTER
30-05-2014 -
|
Biotechnology Value Fund II, L.P. |
NB FP INVESTMENT II K/S |
EJERREGISTER
30-05-2014 -
|
Thue Walter Schwartz |
NORDIC BIOTECH INCENTIVE ApS |
EJERREGISTER
31-05-2005 -
|
Thue Walter Schwartz |
NORDIC BIOTECH PRIVATE INVESTORS ApS |
EJERREGISTER
13-06-2006 -
|
Morten Skjønnemand |
FWP IP ApS |
Reelle ejere
22-11-2017 -
Bestyrelse 22-11-2017 - |
Vibeke Bisgaard Ackermann |
NB PUBLIC EQUITY INVEST ApS |
Direktion
31-01-2021 -
|
Vibeke Bisgaard Ackermann |
NB PUBLIC EQUITY KOMPLEMENTAR ApS |
Direktion
31-01-2021 -
|
Jann Saxtorph Haagaard |
FWP IP ApS |
Reelle ejere
22-11-2017 -
Bestyrelse 22-11-2017 - |
Mark Earl Hensley |
VELOXIS PHARMACEUTICALS A/S |
Direktion
08-11-2021 -
|
Asahi Kasei Corporation |
VELOXIS PHARMACEUTICALS A/S |
EJERREGISTER
04-01-2021 -
|
Benjamin Rupert Lars Iversen |
NORDIC BIOTECH PRIVATE INVESTORS ApS |
Stiftere
28-09-2001 -
|
Daisuke Matsuo |
VELOXIS PHARMACEUTICALS A/S |
Bestyrelse
17-02-2020 -
|
dorte Kloppenborg Skrumsager |
NORDIC BIOTECH PRIVATE INVESTORS ApS |
Stiftere
28-09-2001 -
|
Manhattan Pharmaceuticals Inc |
H PHARMACEUTICALS GENERAL PARTNER ApS |
Stiftere
25-02-2008 -
|
Duncan Moore |
NORDIC BIOTECH PRIVATE INVESTORS ApS |
Stiftere
28-09-2001 -
|
VækstFonden |
NORDIC BIOTECH GENERAL PARTNER ApS |
Stiftere
28-09-2001 -
|
William A Scott |
NORDIC BIOTECH INCENTIVE ApS |
Stiftere
03-10-2001 -
|
BVF/NexGen Investments, L.P |
NORDIC BIOTECH GENERAL PARTNER ApS |
Stiftere
28-09-2001 -
|
HBM Healthcare Investments (Cayman) Ltd |
NORDIC BIOTECH K/S |
EJERREGISTER
31-07-2002 -
|
BVF/NexGen Biotech, L.P. |
NB FP INVESTMENT SLP ApS |
EJERREGISTER
08-09-2014 -
|
BVF/Nexgen Investments, L.P. |
NORDIC BIOTECH K/S |
EJERREGISTER
31-07-2002 -
|
European Investment Fund |
NORDIC BIOTECH K/S |
EJERREGISTER
31-07-2002 -
|
HBM Healthcare Investments (Cayman) Ltd |
NORDIC BIOTECH OPPORTUNITY FUND K/S |
EJERREGISTER
29-02-2008 -
|
Benjamin Rupert Lars Iversen |
NORDIC BIOTECH PRIVATE INVESTORS ApS |
EJERREGISTER
11-12-2014 -
|
Torsten Goesch |
FORWARD PHARMA A/S |
Bestyrelse
09-06-2006 -
|
Matthew Daniel Perry |
NORDIC BIOTECH ADVISORS ApS |
Bestyrelse
21-01-2002 -
|
BVF/NexGen Biotech, L.P. |
NB FP INVESTMENT GENERAL PARTNER ApS |
EJERREGISTER
04-01-2013 -
|
BVF/Nexgen Biotech, LP |
NORDIC BIOTECH ADVISORS ApS |
EJERREGISTER
28-09-2001 -
|
Lars Grønborg Eskesen |
NORDIC BIOTECH INCENTIVE ApS |
EJERREGISTER
01-05-2003 -
|
Dan Moalem |
TECH GROWTH INVEST ApS |
Bestyrelse
31-05-2002 -
|
Mikkel Kaasgaard Rasmussen |
NUEVOLUTION A/S |
Bestyrelse
11-11-2021 -
|
Alex Haahr Gouliaev |
NUEVOLUTION A/S |
Direktion
02-09-2005 -
|
Tore von Würden Petersen |
NUEVOLUTION A/S |
Bestyrelse
02-08-2019 -
|
Leif Helth Jensen |
NORDIC BIOTECH INCENTIVE ApS |
Stiftere
03-10-2001 -
|
Carsten Bech |
NUEVOLUTION A/S |
Bestyrelse
21-07-2021 -
|
Duncan Moore |
FORWARD PHARMA A/S |
Bestyrelse
06-05-2016 -
|
Thomas Hagen Weisbjerg |
Forward Pharma FA ApS |
Likvidator
09-03-2023 -
|
Grant Hellier Lawrence |
FORWARD PHARMA A/S |
Bestyrelse
20-07-2015 -
|
Yusuke Hiramatsu |
VELOXIS PHARMACEUTICALS A/S |
Bestyrelse
31-08-2022 -
|
Peter Moldt |
NORDIC BIOTECH PRIVATE INVESTORS ApS |
EJERREGISTER
13-06-2006 -
|
Keigo Nakatsukasa |
VELOXIS PHARMACEUTICALS A/S |
Bestyrelse
22-05-2023 -
|
BVF/Nexgen Investments, LP |
NORDIC BIOTECH GENERAL PARTNER ApS |
EJERREGISTER
20-06-2002 -
|
BVF/NexGen Biotech, L.P. |
NB PUBLIC EQUITY INVEST ApS |
EJERREGISTER
07-01-2013 -
|
Lars Folke Henrik Nilsson |
NORDIC BIOTECH INCENTIVE ApS |
EJERREGISTER
27-09-2009 -
|
Tamas Bartfai |
NORDIC BIOTECH INCENTIVE ApS |
Stiftere
03-10-2001 -
|
Biotechnology Value Fund, L.P. |
NB FP INVESTMENT II K/S |
EJERREGISTER
30-05-2014 -
|
Foundation Asset Management AB |
NORDIC BIOTECH K/S |
EJERREGISTER
26-03-2015 -
|
European Investment Fund |
NORDIC BIOTECH OPPORTUNITY FUND K/S |
EJERREGISTER
29-02-2008 -
|
Foundation Asset Management AB |
NORDIC BIOTECH OPPORTUNITY FUND K/S |
EJERREGISTER
26-03-2015 -
|
BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) |
FORWARD PHARMA A/S |
EJERREGISTER
11-03-2022 -
|